LEAN Mass Preservation With Resistance Exercise and Protein During Semaglutide/Tirzepatide Therapy
Clinical trial NCT06885736 · RECRUITING
Trial details
- NCT number
- NCT06885736
- Sponsor
- Dasman Diabetes Institute
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-07
- Primary completion
- 2029-08-30
- Enrollment
- 232
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.